Thyroid and Breast Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Thyroid and Breast Surgery, The second Affiliated Hospital of Zunyi Medical University, Intersection of Xinpu Avenue and Xinlong Avenue in Xinpu New District, Zunyi, Guizhou, China.
Cancer Gene Ther. 2022 Mar;29(3-4):383-395. doi: 10.1038/s41417-021-00348-y. Epub 2021 May 27.
MicroRNAs (miRNA) have been shown to be associated with tumor diagnosis, prognosis, and therapeutic response. MiR-328-3p plays a significant role in breast cancer growth; however, its actual function and how it modulates specific biological functions is poorly understood. Here, miR-328-3p was significantly downregulated in breast cancer, especially in patients with metastasis. Mitochondrial carnitine palmitoyl transferase 1a (CPT1A) is a downstream target gene in the miR-328-3p-regulated pathway. Furthermore, the miR-328-3p/CPT1A/fatty acid β-oxidation/stemness axis was shown responsible for breast cancer metastasis. Collectively, this study revealed that miR-328-3p is a potential therapeutic target for the treatment of breast cancer patients with metastasis, and also a model for the miRNA-fatty acid β-oxidation-stemness axis, which may assist inunderstanding the cancer stem cell signaling functions of miRNA.
微小 RNA(miRNA)已被证明与肿瘤的诊断、预后和治疗反应有关。miR-328-3p 在乳腺癌的生长中起着重要作用;然而,其实际功能及其如何调节特定的生物学功能仍知之甚少。在这里,miR-328-3p 在乳腺癌中显著下调,尤其是在有转移的患者中。线粒体肉碱棕榈酰转移酶 1a(CPT1A)是 miR-328-3p 调控途径的下游靶基因。此外,miR-328-3p/CPT1A/脂肪酸β-氧化/干性轴被证明负责乳腺癌转移。总之,这项研究表明 miR-328-3p 是治疗有转移的乳腺癌患者的潜在治疗靶点,也是 miRNA-脂肪酸β-氧化-干性轴的模型,这可能有助于理解 miRNA 对癌症干细胞信号的功能。